Found: 14
Select item for more details and to access through your institution.
Safety and efficacy of S-1 plus oxaliplatin 130 mg/m2 combination therapy in patients with previously untreated HER2-negative unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: a phase II trial (KSCC1501A).
- Published in:
- International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 345, doi. 10.1007/s10147-020-01803-w
- By:
- Publication type:
- Article
Phase II clinical trial of gemcitabine plus oxaliplatin in patients with metastatic pancreatic adenocarcinoma with a family history of pancreatic/breast/ovarian/prostate cancer or personal history of breast/ovarian/prostate cancer (FABRIC study).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 10, p. 1835, doi. 10.1007/s10147-020-01721-x
- By:
- Publication type:
- Article
Prognostic scores for evaluating the survival benefit of regorafenib or trifluridine/tipiracil in patients with metastatic colorectal cancer: an exploratory analysis of the REGOTAS study.
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 4, p. 614, doi. 10.1007/s10147-019-01600-0
- By:
- Publication type:
- Article
Genomic characterization between HER2‐positive and negative gastric cancer patients in a prospective trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 15, p. 16649, doi. 10.1002/cam4.6269
- By:
- Publication type:
- Article
Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 454, doi. 10.1002/cam4.3618
- By:
- Publication type:
- Article
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil Treatment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.688709
- By:
- Publication type:
- Article
Survival Benefit of Crossover Administration of Regorafenib and Trifluridine/Tipiracil Hydrochloride for Patients With Metastatic Colorectal Cancer: Exploratory Analysis of a Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study (REGOTAS)
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.576036
- By:
- Publication type:
- Article
Detection of KRAS Mutations in Plasma DNA Using a fully Automated Rapid Detection System in Colorectal Cancer Patients.
- Published in:
- Pathology & Oncology Research, 2017, v. 23, n. 4, p. 737, doi. 10.1007/s12253-016-0175-1
- By:
- Publication type:
- Article
Role of Predictive Value of the Modified Glasgow Prognostic Score for Later-line Chemotherapy in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multicenter phase II study of SOX plus trastuzumab for patients with HER2<sup>+</sup> metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
- Published in:
- Gastric Cancer, 2023, v. 26, n. 6, p. 1020, doi. 10.1007/s10120-023-01423-z
- By:
- Publication type:
- Article
Propensity Score Analysis of Regorafenib Versus Trifluridine/Tipiracil in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy (REGOTAS): A Japanese Society for Cancer of the Colon and Rectum Multicenter Observational Study.
- Published in:
- Oncologist, 2018, v. 23, n. 1, p. 7, doi. 10.1634/theoncologist.2017-0275
- By:
- Publication type:
- Article
MicroRNAs associated with postoperative outcomes in patients with limited stage neuroendocrine carcinoma of the esophagus.
- Published in:
- Oncology Letters, 2023, v. 26, n. 1, p. N.PAG, doi. 10.3892/ol.2023.13862
- By:
- Publication type:
- Article